Greetings:
A special shout to Kathleen Koechlin, Ohio's Adult Viral Hepatitis Coordinator, and the people who attended the Basic and Advanced HCV Training workshops we conducted last week. It was a privilege to provide everyone with the knowledge that will help them in their mission to provide so badly needed support and services for the hepatitis C community.
In this week's eblast we have the following items newly posted to our websites:
1. August 2012 HCV Advocate
In This Issue:
- Cure: Really? by Alan Franciscus, Editor-in-Chief – read a summary from a study that addresses scientifically whether successful treatment of HCV is really a cure.
- HCV Snapshots by Lucinda K. Porter, RN – read about the benefits of treatment even without a cure, the effect of insulin resistance on fibrosis progression, how higher ribavirin dose affects re-treatment, and a study on the prevalence of HCV among the homeless population in Los Angeles.
- Disability & Benefits: What Happens When COBRA Ends by Jacques Chambers, CLU – discusses what you need to know about COBRA.
- HealthWise: Medically-Acquired Hepatitis C by Lucinda K. Porter, RN – about the Exeter Hospital outbreak and medical errors in general.
- HCV Increases the Risk of Non-Liver Deaths by Alan Franciscus, Editor-in-Chief – this first of its kind study looks at deaths in people with hepatitis C and documents the increases in non-liver deaths in people with hepatitis C.
- Curing Fatigue with Treatment by Alan Franciscus, Editor-in-Chief – fatigue is the most common symptom of people with hepatitis C --this study is the first to show that HCV treatment can improve fatigue including the severe fatigue that some experience.
2. HBV Journal Review by Christine Kukka – in this month's Review Chris discusses the following news and journal items:
- Few Restrictions Recommended for HBV-Infected Doctors and Medical Students
- Hepatitis B Continues to Be Under-Diagnosed and Under-Treated in the U.S.
- Only 6% of Patients at Risk of Liver Cancer Are Properly Screened in the U.S.
- Treatment with Potent Antivirals Prolong Life and Is Cost-Effective
- U.S. Patients Follow Doctors’ Order and Take Antivirals as Prescribed
- Experts Suggest "Healthy" ALT Levels Should Be Lowered to 17 and 21 IU/L
- Hepatitis B Does Not Impact Quality of Life until Severe Cirrhosis or Liver Cancer Occur
- Another Study Shows Interferon Effective in Patients with HBV Genotype B
- New Study Confirms the Safety of Antiviral Treatment in Pregnant Women
- Vitamin B12 Helps Hepatitis C Patients Treated with Interferon and Antiviral
- Vitamin E May Decreases Liver Cancer Risk
3. Factsheets and Guides – we continue to update our fact sheets and guides.
Check out these newly updated fact sheets:
and don’t forget our updated “Treatment Issues Guides,” such as
4. Training Schedule – Don’t forget to keep checking our Upcoming Training Workshop Schedules to see if we will be in your neighborhood soon!
HCV
HBV
Don’t forget that there is help as close as a phone call – the 877-HELP-4-HEP line (877-435-7443) is available 9:00am to 7:00pm Eastern Time. For more information about the services they offer either call or visit their Website at www.help4hep.org The helpline is run by The Support Partnership: a group of non-profits working together to help people affected by hepatitis C.
.
5. Top News (Blog) from the hepatitis blog includes:
and much, much more…..
Sincerely,
Alan
Alan Franciscus
Executive Director, Hepatitis C Support Project
Editor-in-Chief, HCV Advocate www.hcvadvocate.org
Editor-in-Chief, HBV Advocate www.hbvadvocate.org
**Questions and Comments: Questions and/or comments can be directed to alanfranciscus@hcvadvocate.org
**To receive the eblast in your email inbox simply send an e-mail to: listserv@list.hcvadvocate.org with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.
|
